MiR-767-3p promotes the progression of hepatocellular carcinoma via targeting CASP-3/-9

CONCLUSION: MiR-767-3p promoted proliferation and prevented apoptosis in human hepatocellular carcinoma (HCC) through inhibiting the caspase-3/caspase-9 pathway.PMID:37193190 | PMC:PMC10182511

Source: American Journal of Translational Research - May 16, 2023 Category: Research Authors: Maolin Wu Jing Deng Dejiao Yao Shijie Li Source Type: research